Black Rock Inc. C4 Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,551,510 shares of CCCC stock, worth $13.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,551,510

Previous 905,006 402.93%

Holding current value

$13.2 Million

Previous $7.39 Million 184.42%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.05 - $8.1 $14.8 Million - $29.5 Million	3,646,504 Added 402.93%	4,551,510 $21 Million
Q1 2024 May 10, 2024	SELL	$5.3 - $11.0 $4.76 Million - $9.88 Million	-898,427 Reduced 49.82%	905,006 $7.39 Million
Q4 2023 Feb 13, 2024	SELL	$1.18 - $6.03 $344,447 - $1.76 Million	-291,905 Reduced 13.93%	1,803,433 $10.2 Million
Q3 2023 Nov 13, 2023	BUY	$1.81 - $3.89 $15,882 - $34,134	8,775 Added 0.42%	2,095,338 $3.9 Million
Q2 2023 Aug 11, 2023	SELL	$2.75 - $3.77 $4.43 Million - $6.07 Million	-1,610,179 Reduced 43.56%	2,086,563 $5.74 Million
Q1 2023 May 12, 2023	BUY	$3.1 - $9.02 $234,387 - $681,993	75,609 Added 2.09%	3,696,742 $11.6 Million
Q4 2022 Feb 13, 2023	BUY	$5.42 - $10.24 $848,560 - $1.6 Million	156,561 Added 4.52%	3,621,133 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $537,801 - $855,257	66,974 Added 1.97%	3,464,572 $30.4 Million
Q2 2022 Aug 12, 2022	BUY	$5.06 - $26.46 $1.3 Million - $6.82 Million	257,608 Added 8.2%	3,397,598 $25.6 Million
Q1 2022 May 12, 2022	SELL	$19.99 - $33.23 $5.32 Million - $8.84 Million	-265,992 Reduced 7.81%	3,139,990 $76.2 Million
Q4 2021 Feb 10, 2022	BUY	$29.39 - $46.86 $7.31 Million - $11.7 Million	248,775 Added 7.88%	3,405,982 $110 Million
Q3 2021 Nov 09, 2021	BUY	$35.91 - $50.5 $18.8 Million - $26.5 Million	524,783 Added 19.94%	3,157,207 $141 Million
Q2 2021 Aug 11, 2021	BUY	$30.39 - $42.18 $80 Million - $111 Million	2,632,424 New	2,632,424 $99.6 Million

Others Institutions Holding CCCC

# of Institutions

126

Shares Held

63M

Call Options Held

651K

Put Options Held

115K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $141M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account